Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) announces an educational webinar exploring the evolution of PSMA1-targeted radionuclide therapy and ...

Gosatomnadzor has found no excess of radionuclides in water or food in the contaminated zone in recent years, First Deputy ...

Expert Nikolay Kovalev added that by 2056, plutonium-241 will account only for 3.3% of the amount released into the environment, and its prevalence will decrease ...

Radiopharmaceuticals are one of the most exciting frontiers in oncology and targeted therapies today. By combining biologically active molecules with radionuclides, radiopharmaceuticals can deliver ...

When nuclear accidents happen, many people imagine radiation spreading everywhere and lasting forever. The reality is more ...

Comparative analysis of stereotactic body radiotherapy (SBRT) vs. SBRT with bridge therapies for hepatocellular carcinoma patients awaiting liver transplantation: A multi-center study (2010-2020).

Use of an approved radionuclide therapy for difficult-to-treat meningioma was associated with substantially improved progression-free survival (PFS) compared with a historical benchmark, according to ...

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), is delighted to be working with Brookline Capital Markets at the 2nd Targeted Radionuclide Pharmaceuticals (TRPs) ...

Toronto, Ontario—Combination of alpha- and beta-radionuclide therapy is feasible, tolerable, and effective for colorectal cancer, according to preclinical research presented at the 2024 Society of ...

Researchers led by teams at the Institute for Bioengineering of Catalonia (IBEC) and CIC biomaGUNE demonstrated how a single dose of urea-powered, radionuclide-carrying nanorobots successfully reduced ...

RICHLAND, WA - (NewMediaWire) - December 20, 2023-- Vivos Inc. (OTCQB: RDGL), is pleased to announce that the Food and Drug Administration has granted RadioGel Precision Radionuclide Therapy the ...